Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a. (Q51975208)

19 April 2018

title

Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a. (English)

1 reference

19 April 2018

1 reference

Doo-Hee Shim

1

1 reference

19 April 2018

Sun-Young Chang

2

1 reference

19 April 2018

Sung-Moo Park

3

1 reference

19 April 2018

Hyun Jang

4

1 reference

19 April 2018

Rodney Carbis

5

1 reference

19 April 2018

Cecil Czerkinsky

6

1 reference

19 April 2018

Satoshi Uematsu

7

1 reference

19 April 2018

Shizuo Akira

8

1 reference

19 April 2018

Mi-Na Kweon

9

1 reference

19 April 2018

language of work or name

English

0 references

publication date

20 April 2007

1 reference

19 April 2018

published in

Vaccine

1 reference

19 April 2018

volume

25

1 reference

19 April 2018

page(s)

4828-4836

1 reference

19 April 2018

issue

25

1 reference

19 April 2018

War and peace at mucosal surfaces

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Mucosal immunity and vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Role of gut-associated lymphoreticular tissues in antigen-specific intestinal IgA immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Prenatal blockage of lymphotoxin beta receptor and TNF receptor p55 signaling cascade resulted in the acceleration of tissue genesis for isolated lymphoid follicles in the large intestine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Toll-like receptor signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Innate secretory antibodies protect against natural Salmonella typhimurium infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Effectiveness of ribosomal fractions of Klebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and the membrane fraction of Kp (Ribomunyl) in the prevention of clinical recurrences of infectious rhinitis. Res

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Polysaccharide nature of O antigen in protective ribosomal preparations from Shigella: Experimental evidence and implications for the ribosomal vaccine concept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Let's go mucosal: communication on slippery ground

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Facilitated production of secretory IgA against Shiga toxin B subunits by intranasal application of antigen-coated polystyrene microspheres.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Shigella infection in a SCID mouse-human intestinal xenograft model: role for neutrophils in containing bacterial dissemination in human intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Control of B-cell responses by Toll-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

7 January 2021

Microbial ribosomal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

7 January 2021

Parenteral immunization with Shigella ribosomal vaccine elicits local IgA response and primes for mucosal memory.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

7 January 2021

Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

7 January 2021

Requirement of the conformational stability of a Salmonella ribosomal vaccine for its mouse protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

7 January 2021

Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.050

7 January 2021

10.1016/J.VACCINE.2007.03.050

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

17507120

1 reference

19 April 2018